(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 38.92 | 36.62 | 6.28 | 114.48 | 115.68 | -1.04 | 131.29 | 223.62 | -41.29 |
| Other Income | 0.62 | 1.16 | -46.55 | 1.07 | 1.55 | -30.97 | 3.76 | 5.22 | -27.97 |
| PBIDT | 1.57 | 1.69 | -7.10 | 6.41 | 5.10 | 25.69 | 4.06 | 9.80 | -58.57 |
| Interest | 0.05 | 0.01 | 400.00 | 0.11 | 0.06 | 83.33 | 0.07 | 0.13 | -46.15 |
| PBDT | 1.52 | 1.68 | -9.52 | 6.30 | 5.04 | 25.00 | 3.99 | 9.63 | -58.57 |
| Depreciation | 0.52 | 0.66 | -21.21 | 1.59 | 2.07 | -23.19 | 2.80 | 3.58 | -21.79 |
| PBT | 1.00 | 1.02 | -1.96 | 4.71 | 2.97 | 58.59 | 1.19 | 6.05 | -80.33 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.40 | 2.95 | -86.44 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 1.13 | -92.04 |
| PAT | 1.00 | 1.02 | -1.96 | 4.71 | 2.97 | 58.59 | 0.79 | 3.10 | -74.52 |
| Equity | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 | 53.74 | 53.74 | 0.00 |
| PBIDTM(%) | 4.03 | 4.61 | -12.59 | 5.60 | 4.41 | 27.00 | 3.09 | 4.38 | -29.44 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1818.80 |
| Dr. Reddys Lab | 1276.75 |
| Cipla | 1330.25 |
| Zydus Lifesciences | 907.55 |
| Lupin | 2331.70 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: